Amytrx Therapeutics
Dr. Danny Helton is Vice President of Chemistry and Manufacturing of drug product at Amytrx and is responsible for the company’s regulatory, commercial and clinical drug product development efforts. Dr. Helton has more than 30 years of experience in CMC, having previously contributed to the discovery of seven approved drug products and substances in the US and internationally, including medical device and pharmaceutical products in dermatology and ophthalmology. Dr. Helton received his Ph.D. in Organic Chemistry from the University of Louisville.
This person is not in any offices
Amytrx Therapeutics
Amytrx Therapeutics is advancing a new class of peptide therapies to overcome inflammatory diseases—with a vision of providing transformative medicines to patients.